Canada Pension Plan Investment Board
IBRX icon

Canada Pension Plan Investment Board’s ImmunityBio IBRX Stock Holding History

Canada Pension Plan Investment Board’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$648K Sell
84,500
-88,300
-51% -$604K ﹤0.01% 1141
2025
Q4 		$342K Buy
+172,800
New +$391K ﹤0.01% 1460
2019
Q2 		– Sell
-200
Closed – – 1352
2019
Q1 		$0 Buy
+200
New +$251 ﹤0.01% 1573

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Canada Pension Plan Investment Board's IBRX Position: Q1 2026 in Review

Canada Pension Plan Investment Board reduced its ImmunityBio (IBRX) stake by 51% in Q1 2026, selling an estimated $604K and leaving 84,500 shares worth $648K. The position accounts for ﹤0.01% of the portfolio, ranked #1141.

Canada Pension Plan Investment Board first reported a position in IBRX in Q1 2019 and has held it in 3 quarters since. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Canada Pension Plan Investment Board held 84,500 shares of ImmunityBio worth $648K as of Q1 2026.
  • Canada Pension Plan Investment Board sold 88,300 ImmunityBio shares in Q1 2026, an estimated $604K.
  • ImmunityBio made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1141 holding.
  • Canada Pension Plan Investment Board first reported a position in ImmunityBio in Q1 2019 and has held it in 3 quarters since.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.